Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhanvanthri S Deevi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biochemical and Biophysical Research Communications|April 28, 2007
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibodyJuqun Shen, Marie D Vil, Haifan Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationshipVedula M Sharma, P Prasanna, K V Adi Seshu, et al.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biochemical and Biophysical Research Communications|April 28, 2007
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibodyJuqun Shen, Marie D Vil, Haifan Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationshipVedula M Sharma, P Prasanna, K V Adi Seshu, et al.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Pageof 2